Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mayne Pharma Group ( (AU:MYX) ) has issued an update.
UBS Group AG and its related bodies corporate have increased their voting power in Mayne Pharma Group Limited from 7.40% to 8.79% as of April 24, 2025. This change in substantial holding reflects UBS’s strategic interest in Mayne Pharma, potentially impacting the company’s market influence and shareholder dynamics.
More about Mayne Pharma Group
YTD Price Performance: 50.52%
Average Trading Volume: 2,033
Technical Sentiment Signal: Sell
Current Market Cap: $364.5M
Learn more about MYX stock on TipRanks’ Stock Analysis page.